Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

JuanValle Raleigh; Adolfo G.Mauro; TejaDevarakonda; CarloMarchetti; JunHe; EricaKim; ScottFilippone; AninditaDas; StefanoToldo; AntonioAbbate; Fadi N.Salloum

首页> 外文期刊>Cardiovascular Research >Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

【24h】

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

机译：再灌注治疗重组人胃弛豫素-2（Serelaxin）衰减通过依赖机构缺血/再灌注损伤后的心肌梗塞尺寸和NLRP3炎性组

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Cardiovascular Research》 |2017年第6期|共11页
作者
JuanValle Raleigh; Adolfo G.Mauro; TejaDevarakonda; CarloMarchetti; JunHe; EricaKim; ScottFilippone; AninditaDas; StefanoToldo; AntonioAbbate; Fadi N.Salloum;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism [J] . JuanValle Raleigh, Adolfo G.Mauro, TejaDevarakonda, Cardiovascular Research . 2017,第6期

机译：再灌注治疗重组人胃弛豫素-2（Serelaxin）衰减通过依赖机构缺血/再灌注损伤后的心肌梗塞尺寸和NLRP3炎性组
2. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. [J] . Yi Liu, Kun Lian, Lijian Zhang, Basic Research in Cardiology: Official Journal of the German Association of Cardiovascular Research . 2014,第5期

机译：TXNIP介导心脏微血管内皮细胞中的NLRP3炎性体激活，作为心肌缺血/再灌注损伤的新机制。
3. Human Recombinant Apyrase Therapy Protects Against Myocardial Ischemia/Reperfusion Injury and Preserves Left Ventricular Systolic Function in Rats, as Evaluated by 7T Cardiovascular Magnetic Resonance Imaging [J] . Ziqian Xu, Wei Chen, Ruzhi Zhang, Korean journal of radiology : . 2020,第6期

机译：人重组屏骨酶治疗可防止心肌缺血/再灌注损伤，并在大鼠中保留左心室收缩功能，如7T心血管磁共振成像评估
4. Investigation on the treatment of myocardial ischemia-reperfusion injury(MIRI) with Tanyu Recipe based on integrated pharmacology platform V2.0 Molecular Mechanism Research [C] . Hongjie Gao, Sihong Liu, Lei Zhang, IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：基于综合药理学平台的坦苗配方对心肌缺血再灌注损伤（Miri）治疗的调查v2.0分子机制研究
5. Ultrasound-Mediated S100A6 Gene Therapy Ameliorates Myocardial Ischemia/Reperfusion (I/R) Injury. [D] . Mofid, Azadeh. 2016

机译：超声介导的S100A6基因治疗可改善心肌缺血/再灌注（I / R）损伤。
6. Mild Hypothermia Therapy Lowers the Inflammatory Level and Apoptosis Rate of Myocardial Cells of Rats with Myocardial Ischemia-Reperfusion Injury via the NLRP3 Inflammasome Pathway [O] . Renjun Gao, Hongye Zhao, Xianyan Wang, 2021

机译：轻度体温过低治疗降低了通过NLRP3炎症途径对大鼠心肌缺血再灌注损伤的大鼠心肌细胞的炎症水平和凋亡率
7. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism [O] . Juan Valle Raleigh, Adolfo G. Mauro, Teja Devarakonda, 2017

机译：再灌注治疗重组人胃弛豫素-2（Serelaxin）衰减通过依赖机构缺血/再灌注损伤后的心肌梗塞尺寸和NLRP3炎性组

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

著录项

引文网络

相似文献

相关主题

期刊订阅